Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Breast screening programme started in Spain:

This article was originally published in Clinica

Executive Summary

Insalud, the Spanish health agency, has signed an agreement with the Spanish Association Against Cancer (AECC) to set up a two-year screening programme for breast cancer in women aged between 50 and 64. The mammograms will be carried out by AECC clinics and mobile units and anyone who is suspected of having cancer will then be sent to Insalud hospitals to undergo further tests. By freeing its machines from the initial screening phase, Insalud, which provides healthcare for the regions that have not yet become autonomous, hopes to reduce the waiting time for breast cancer diagnosis. Breast cancer is the primary cause of cancer deaths in Spanish women.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT083089

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel